Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 74 (RPSAP74) is a processed pseudogene of the ribosomal protein SA gene (RPSA), which means it is a nonfunctional genomic sequence derived from the retrotransposition or duplication of the parent gene. While the RPSA gene produces a protein with multiple roles—including association with the ribosome and functioning as a laminin receptor—the RPSAP74 pseudogene does not produce a functional protein and has no known direct biological or pathological role. Pseudogenes like RPSAP74 are a common genomic feature, and while some may produce regulatory RNA in certain cases, there is no evidence so far that RPSAP74 has any such function[2][3][6]. RPSAP74 is a *pseudogene* (non-functional gene fragment) and is not considered a molecular or therapeutic target. If a therapeutic focus is required, information should instead be gathered for the functional RPSA gene/protein[1][7].
None (not a functional gene or protein)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 74 (RPSAP74).